Biogen Inc. Stock Chart

Biogen Inc. (XETR) · Health Technology. stock live price and technical analysis view. Follow XETRA data on Alerta Chart.

Checking data access...

About Biogen Inc.

XETR
Market Cap
19.43B
P/E Ratio
14.77
Shares Out.
146.61M
Sector
Health Technology
Industry
Pharmaceuticals: Major

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

www.biogen.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
IDP.DE (IDP.DE) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart